Cite
HARVARD Citation
Khanna, S. et al. (n.d.). S131 CP101, an Investigational Orally Administered Microbiome Therapeutic, Increases Intestinal Microbiome Diversity and Prevents Recurrent C. difficile Infection: Results From a Randomized, Placebo-Controlled Trial. American journal of gastroenterology. p. S57. [Online].